In a mouse model with a gain-of-function mutation of NLRP3, the NLRP3 inflammasome activation by systemic LPS injection leads to cochlear inflammation and SNHL, hinting at the role of the NLRP3 inflammasome in the ear [37]. This evidence concerns the gene NLRP3 and sensorineural hearing loss disorder.